A Phase I Clinical Trial on Decitabine (5-aza-2'-Deoxycytidine) Administered by Hepatic Arterial Infusion in Patients With Unresectable Liver-predominant Metastases From Colorectal Cancer
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Decitabine (Primary)
- Indications Colorectal cancer; Liver cancer
- Focus Adverse reactions
- 14 Sep 2016 Planned End Date changed from 1 Jul 2016 to 1 Jul 2017.
- 14 Sep 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Dec 2016.
- 12 Jan 2016 Planned End Date changed from 1 Jun 2016 to 1 Jul 2016 as reported by ClinicalTrials.gov record.